FF:0000335: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{F5terms | {{F5terms | ||
| | |alt_id= | ||
|comment= | |comment= | ||
|created_by=tmeehan | |created_by=tmeehan | ||
| | |def= | ||
|derives_from= | |derives_from= | ||
|develops_from= | |develops_from= | ||
|disjoint_from= | |||
|has_quality= | |has_quality= | ||
|id=FF:0000335 | |||
|is_a=EFO:0000369 ;;FF:0000625 | |||
|is_obsolete= | |||
|located_in= | |located_in= | ||
|name=LPS treatment sample | |||
|namespace=FANTOM5 | |||
|obo_creation_date=2011-04-29T09:45:03Z | |||
|part_of= | |part_of= | ||
|preceded_by= | |||
|property_value= | |property_value= | ||
| | |subset= | ||
| | |synonym="lipopolysaccharide treatment" RELATED [] | ||
|union_of= | |||
|xref= | |||
}} | }} | ||
Latest revision as of 16:55, 12 September 2014
outline
- id: FF:0000335
- name: LPS treatment sample
- namespace: FANTOM5
- synonym: "lipopolysaccharide treatment" RELATED []
- created_by: tmeehan
- creation_date: 29 April 2011 09:45:03
- CAGEd oPOSSUM: NA
Ontology association
Parents
| is_a: | EFO:0000369(compound based treatment),FF:0000625(experimental infection sample) |
|---|
Children
| is a: | FF:0000566 (human Monocyte-derived macrophages 0min after LPS treatment sample),FF:0000567 (human Monocyte-derived macrophages 15min after LPS treatment sample),FF:0000568 (human Monocyte-derived macrophages 30min after LPS treatment sample),FF:0000569 (human Monocyte-derived macrophages 45min after LPS treatment sample),FF:0000570 (human Monocyte-derived macrophages 1h after LPS treatment sample),FF:0000571 (human Monocyte-derived macrophages 80min after LPS treatment sample),FF:0000572 (human Monocyte-derived macrophages 100min after LPS treatment sample),FF:0000573 (human Monocyte-derived macrophages 2h after LPS treatment sample),FF:0000574 (human Monocyte-derived macrophages 2.5h after LPS treatment sample),FF:0000575 (human Monocyte-derived macrophages 3h after LPS treatment sample),FF:0000576 (human Monocyte-derived macrophages 3.5h after LPS treatment sample),FF:0000577 (human Monocyte-derived macrophages 4h after LPS treatment sample),FF:0000578 (human Monocyte-derived macrophages 5h after LPS treatment sample),FF:0000579 (human Monocyte-derived macrophages 6h after LPS treatment sample),FF:0000580 (human Monocyte-derived macrophages 7h after LPS treatment sample),FF:0000581 (human Monocyte-derived macrophages 8h after LPS treatment sample),FF:0000582 (human Monocyte-derived macrophages 10h after LPS treatment sample),FF:0000583 (human Monocyte-derived macrophages 12h after LPS treatment sample),FF:0000584 (human Monocyte-derived macrophages 14h after LPS treatment sample),FF:0000585 (human Monocyte-derived macrophages 16h after LPS treatment sample),FF:0000586 (human Monocyte-derived macrophages 18h after LPS treatment sample),FF:0000587 (human Monocyte-derived macrophages 20h after LPS treatment sample),FF:0000588 (human Monocyte-derived macrophages 22h after LPS treatment sample),FF:0000589 (human Monocyte-derived macrophages 24h after LPS treatment sample),FF:0000590 (human Monocyte-derived macrophages 36h after LPS treatment sample),FF:0000591 (human Monocyte-derived macrophages 48h after LPS treatment sample),FF:0011108 (human CD14-positive monocytes - treated with lipopolysaccharide sample) |
|---|
FF Samples
